MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ: DEPO) today announced that Michael Sweeney, M.D. has joined the company as vice president of Product Development. Dr. Sweeney will implement Depomed’s strategic plan for product development activities, from opportunity assessment through clinical trials and interactions with the FDA. Dr. Sweeney will oversee several key functional areas, including formulations, pharmacokinetics, pre-clinical, clinical development and regulatory affairs. In addition, Dr. Sweeney will be responsible for the commercial medical affairs function at Depomed.
